Leap Therapeutics is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
August 08, 2018Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results
July 23, 2018Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors
June 13, 2018Leap Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference
There are currently no events scheduled.
as of 4:00 PM ETAug 17, 2018
Data provided by Nasdaq. Minimum 15 minutes delayed.